Pbrm1/vimentin axis dictates tumor grade, epithelial-mesenchymal transition, and metastasis in pancreatic cancer
ChIP-seq analysis of mouse pancreatic ductal adenocarcinoma harboring Kras mutation and Trp53 deletion through conditional deletion of Pbrm1 using an antibody against PBRM1, H3K27ac, and IgG antibody